Grifols, SA

GRF.P

Equity

ISIN ES0171996095 / Valor 30689500

BME Bolsas y Mercados Espanoles - Renta Variable (2024-11-20)

EUR 8.10+1.06%

Grifols, SA
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Grifols, SA is a global healthcare company that specializes in the development, production, and distribution of plasma-derived medicines, other biopharmaceuticals, and transfusion medicine solutions. The company plays a critical role in the healthcare sector by providing essential products that support the treatment of various medical conditions and diseases. Grifols' offerings include innovative technologies and products for blood typing, specifically the agglutination technique that uses gel as a reagent for determining blood groups and ensuring transfusion compatibility. This technique is notable for its use of cards with 6 to 8 wells filled with gel for testing purposes. Additionally, Grifols is involved in the production of organic compounds, including those belonging to the amino acid group, which are essential for various bodily functions and are found in some foods of animal origin. The company also prepares medicines for intravenous use, which can be administered through reconstitution or by mixing with existing solutions for fluid therapy. Grifols' commitment to advancing healthcare solutions underscores its position as a leader in the pharmaceutical and biotechnology industries, significantly impacting patient care worldwide.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-7.80%1Y

-21.7%3Y

-59.4%5Y

Performance

85.6%1Y

59.8%3Y

50.2%5Y

Volatility